G. Klein

760 total citations
44 papers, 520 citations indexed

About

G. Klein is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, G. Klein has authored 44 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 13 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in G. Klein's work include Lipoproteins and Cardiovascular Health (7 papers), Cardiac pacing and defibrillation studies (6 papers) and Heart Failure Treatment and Management (5 papers). G. Klein is often cited by papers focused on Lipoproteins and Cardiovascular Health (7 papers), Cardiac pacing and defibrillation studies (6 papers) and Heart Failure Treatment and Management (5 papers). G. Klein collaborates with scholars based in Germany, Finland and United States. G. Klein's co-authors include Stephan Holmer, Heribert Schunkert, Christian Hengstenberg, Marcus Fischer, H. Wollschläger, Winfried März, A. Neiß, Martin Wehling, B. Permanetter and Andrea Baessler and has published in prestigious journals such as Physical Review Letters, Circulation and European Heart Journal.

In The Last Decade

G. Klein

35 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Klein Germany 12 179 165 122 75 69 44 520
Wolfgang Zierhut Germany 19 159 0.9× 1.0k 6.3× 284 2.3× 17 0.2× 76 1.1× 40 1.3k
J. F. Hansen Denmark 18 265 1.5× 505 3.1× 485 4.0× 85 1.1× 210 3.0× 35 1.3k
Makoto Hiramatsu Japan 12 57 0.3× 35 0.2× 133 1.1× 41 0.5× 56 0.8× 54 719
Erwin Garcia United States 18 58 0.3× 109 0.7× 400 3.3× 34 0.5× 156 2.3× 44 890
Mary Lou Gantzer United States 10 89 0.5× 204 1.2× 90 0.7× 9 0.1× 36 0.5× 14 538
CA Smith United States 10 160 0.9× 25 0.2× 66 0.5× 32 0.4× 10 0.1× 16 438
M Brochier France 11 96 0.5× 295 1.8× 101 0.8× 60 0.8× 111 1.6× 72 599
Christopher M. Worrall United States 10 60 0.3× 126 0.8× 187 1.5× 17 0.2× 193 2.8× 12 597
Phillip J. Monaghan United Kingdom 17 194 1.1× 25 0.2× 176 1.4× 52 0.7× 227 3.3× 38 934
Kenichiro Kato Japan 17 326 1.8× 38 0.2× 177 1.5× 42 0.6× 237 3.4× 42 831

Countries citing papers authored by G. Klein

Since Specialization
Citations

This map shows the geographic impact of G. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Klein more than expected).

Fields of papers citing papers by G. Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Klein. The network helps show where G. Klein may publish in the future.

Co-authorship network of co-authors of G. Klein

This figure shows the co-authorship network connecting the top 25 collaborators of G. Klein. A scholar is included among the top collaborators of G. Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Klein. G. Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kakuda, Thomas N., Atef Halabi, G. Klein, et al.. (2023). Pharmacokinetics of JNJ‐73763989 and JNJ‐56136379 (Bersacapavir) in Participants With Moderate Hepatic Impairment. The Journal of Clinical Pharmacology. 63(6). 732–741. 3 indexed citations
3.
Völler, Heinz, Harry Hahmann, H. Gohlke, et al.. (2008). Auswirkung stationärer Rehabilitation auf kardiovaskuläre Risikofaktoren bei Patienten mit koronarer Herzerkrankung. DMW - Deutsche Medizinische Wochenschrift. 124(27). 817–823. 4 indexed citations
4.
5.
Richter, A., H. M. Hafez, Katrin Hartmann, et al.. (2006). Mögliche Gründe für das Versagen einer antibakteriellen Therapie in der tierärztlichen Praxis. 87(8). 624–631. 1 indexed citations
6.
Holmer, Stephan, Heike Bickeböller, Christian Hengstenberg, et al.. (2003). Angiotensin converting enzyme gene polymorphism and myocardial infarction a large association and linkage study. The International Journal of Biochemistry & Cell Biology. 35(6). 955–962. 13 indexed citations
7.
8.
Fischer, Marcus, Christian Hengstenberg, Stephan Holmer, et al.. (2001). ACE-Inhibition bei Myokardinfarktpatienten mit eingeschränkter Ventrikelfunktion: Umsetzung von Therapiestandards in Bevölkerungsstichproben. Zeitschrift für Kardiologie. 90(2). 104–110. 1 indexed citations
9.
Baessler, Andrea, Matthias Fischer, Christian Hengstenberg, et al.. (2001). Die stationäre Rehabilitation verbessert die Umsetzung der Therapierichtlinien zur Sekundärprävention bei Patienten mit koronarer Herzerkrankung. Zeitschrift für Kardiologie. 90(9). 646–654. 4 indexed citations
10.
März, Winfried, H. Wollschläger, G. Klein, A. Neiß, & Martin Wehling. (1999). Safety of low-density lipoprotein cholesterol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE Trial). The American Journal of Cardiology. 84(1). 7–13. 45 indexed citations
11.
Klein, G.. (1998). Combination Therapy with Felodipine and Metoprolol Compared with Captopril and Hydrochlorothiazide. Blood Pressure. 7(5-6). 308–312. 4 indexed citations
12.
Klein, G., et al.. (1997). Effect of metoprolol and amlodipine on myocardial total ischaemic burden in patients with stable angina pectoris. Journal of Clinical Pharmacy and Therapeutics. 22(5-6). 371–378. 2 indexed citations
13.
Permanetter, B., et al.. (1992). Ubiquinone (coenzyme Q10) in the long-term treatment of idiopathic dilated cardiomyopathy. European Heart Journal. 13(11). 1528–1533. 66 indexed citations
14.
Klein, G., et al.. (1990). A Double‐Blind Comparison of Metoprolol CR/ZOK 50 mg and Atenolol 50 mg Once Daily for Uncomplicated Hypertension. The Journal of Clinical Pharmacology. 30(S2). S72–7. 8 indexed citations
15.
Guiraudon, G, et al.. (1990). Anatomically guided surgery to the AV node *1AV nodal skeletonization: experience in 46 patients with AV nodal reentrant tachycardia. European Journal of Cardio-Thoracic Surgery. 4(9). 461–465. 11 indexed citations
16.
Klein, G., et al.. (1984). Antiarrhythmic activity of esmolol (ASL-8052)--a novel ultra-short acting beta-adrenoreceptor blocking agent.. PubMed. 22(2). 112–7. 12 indexed citations
17.
Klein, G., et al.. (1979). Studies on the Pharmacokinetics and Pharmacodynamics of the Beta‐Adrenergic Blocking Agent Sotalol in Normal Man. The Journal of Clinical Pharmacology. 19(8-9). 516–522. 24 indexed citations
18.
Fritz, Hans, et al.. (1970). Isolierung von Trypsininhibitoren und Trypsin-Plasmin-Inhibitoren aus den Samenblasen von Meerschweinchen. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 351(2). 1344–1352. 7 indexed citations
19.
Klein, G., et al.. (1963). Zur röntgenologischen Veränderung der Lungenstruktur nach Unterbindung der Arteria pulmonalis. Lung. 126(5). 318–328. 2 indexed citations
20.
Klein, G.. (1956). Die sekundäre Plombierung der extrafascialen Pneumolyse. Lung. 116(1). 85–90. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wolfgang Zierhut Breakdown of academic impact, for papers by J. F. Hansen Breakdown of academic impact, for papers by Makoto Hiramatsu Breakdown of academic impact, for papers by Erwin Garcia Breakdown of academic impact, for papers by Mary Lou Gantzer Breakdown of academic impact, for papers by CA Smith Breakdown of academic impact, for papers by M Brochier Breakdown of academic impact, for papers by Christopher M. Worrall Breakdown of academic impact, for papers by Phillip J. Monaghan Breakdown of academic impact, for papers by Kenichiro Kato
Rankless by CCL
2026